BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19467986)

  • 1. [Targeted therapies in hepatocellular carcinomas: recent results and future development].
    Marijon H; Faivre S; Raymond E
    Bull Cancer; 2009 May; 96(5):553-61. PubMed ID: 19467986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer.
    Winder T; Lenz HJ
    Gastroenterology; 2010 Jun; 138(6):2163-76. PubMed ID: 20420953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular therapy for the treatment of hepatocellular carcinoma.
    Greten TF; Korangy F; Manns MP; Malek NP
    Br J Cancer; 2009 Jan; 100(1):19-23. PubMed ID: 19018262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma.
    Zhu AX
    Cancer; 2008 Jan; 112(2):250-9. PubMed ID: 18041064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapy of hepatocellular carcinoma: present and future.
    Chan SL; Yeo W
    J Gastroenterol Hepatol; 2012 May; 27(5):862-72. PubMed ID: 22369685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for novel targeted therapies of hepatocellular carcinoma.
    Okamoto K; Neureiter D; Ocker M
    Histol Histopathol; 2009 Apr; 24(4):493-502. PubMed ID: 19224452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW; Poon RT
    Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapies for hepatocellular carcinoma.
    Skelton MR; O'Neil B
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):209-18. PubMed ID: 18391920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Targeted HCC therapies: the door has been opened!].
    Rosmorduc O; Fartoux L
    Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):1-2. PubMed ID: 18341969
    [No Abstract]   [Full Text] [Related]  

  • 10. [Targeted therapies in hepatocellular carcinoma].
    Bouattour M; Marijon H; Dreyer C; Faivre S; Raymond E
    Presse Med; 2010; 39(7-8):753-64. PubMed ID: 20378303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?
    Montella L; Palmieri G; Addeo R; Del Prete S
    World J Gastroenterol; 2016 Jul; 22(27):6114-26. PubMed ID: 27468204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Angiogenesis in Hepatocellular Carcinoma.
    Morse MA; Sun W; Kim R; He AR; Abada PB; Mynderse M; Finn RS
    Clin Cancer Res; 2019 Feb; 25(3):912-920. PubMed ID: 30274981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed therapies in lung cancer: new hope?
    Parente Lamelas I; Abal Arca J; Fírvida Pérez JL
    Arch Bronconeumol; 2012 Oct; 48(10):367-71. PubMed ID: 22551924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].
    Lang A; Graeven U
    Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular changes in hepatocellular carcinoma.
    Yang ZF; Poon RT
    Anat Rec (Hoboken); 2008 Jun; 291(6):721-34. PubMed ID: 18484619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful targeted therapies for hepatocellular carcinoma: are we really getting there?
    Zhu AX
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):499-505. PubMed ID: 18402516
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiangiogenic therapy for gastrointestinal tumors].
    Lakatos G; Tulassay Z
    Orv Hetil; 2008 Dec; 149(49):2317-24. PubMed ID: 19042183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC.
    Pennell NA; Lynch TJ
    Oncologist; 2009 Apr; 14(4):399-411. PubMed ID: 19357226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Targeted therapies in digestive oncology].
    Amram ML; Benamran DA; Roth AD
    Rev Med Suisse; 2011 May; 7(296):1131-2, 1134-6. PubMed ID: 21721202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives.
    Zhu AX
    Semin Oncol; 2012 Aug; 39(4):493-502. PubMed ID: 22846866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.